Pierre Gravier
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Pierre Gravier
Pierre Gravier is recorded as CFO at Ptc Therapeutics, Inc. (PTCT). Ptc Therapeutics, Inc. reported in an 8-K filed July 17, 2023 that Pierre Gravier was appointed Chief Financial Officer, effective July 13, 2023. Pierre Gravier has spoken on 12 earnings calls and 1 other investor event across 1 company, most recently for Ptc Therapeutics, Inc. on July 30, 2026.
“On July 13, 2023, the Board of Directors of PTC Therapeutics, Inc. (the "Company") appointed Pierre Gravier, age 38, as Chief Financial Officer, effective as of July 13, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ptc Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Matthew B. Klein CEO, Board Member
- Matthew B. Klein CEO, Board Member
- Matthew Klein CEO, Board Member
- Michael Schmertzler CFO
- Mark E. Boulding General Counsel
- Christine Utter Chief Accounting Officer
- Allan Jacobson Board Member
- David P. Southwell Board Member
- Hege Sollie-Zetlmayer Board Member
- Jessica Chutter Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.